Is 2013 the Year of Stem Cells?

I’m thinking it is.

Just look at the headlines:

After Successful ALS Phase I, Neuralstem Branches Out  ($CUR)

Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center ($CUR)

Rejuvenated Regenerative Medicine: Stem Cells and Athersys on the Rise ($ATHX)

Athersys’ MultiStem Platform Tempts Big Pharma And Investors ($ATHX)

Meanwhile, $ATHX daily chart shows a cup & handle pattern with one giant handle:


Is this a good sign with a big handle?  Beat me!  Nevertheless, the chart does look like it has a lot of support in the $1.50 area going back to last year.

$CUR daily chart, on the other hand, is showing a come-back V shape pattern:


I like to see price action breakout of the downtrend line at the $1.20 area to show that it means business.

Either way, I’m betting my 2 cents that 2013 may be a good year for Stem Cells.  And I’m rooting for $CUR to have a successful ALS phase II trial.  It will be a milestone for those who suffers from the disease.

I currently own both $CUR and $ATHX.

My 2 cents.


Categories: ATHX, CUR

Tags: , , ,

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: